Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Nepal study fights stigma to help gender-diverse people get HIV testing and care

NCT ID NCT07528573

Knowledge-focused Sponsor: Public Health Foundation Enterprises, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a 5-month group program called Sweekar to reduce stigma and increase HIV testing and medication adherence among transgender and gender-diverse adults in Nepal. 31 participants joined group sessions to address social stigma and HIV prevention needs. The study measured how many used HIV self-test kits and how well they stuck to HIV treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

31 people

The number who actually took part.

Started

May 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. aged 18 years old or older 2. identify as transgender, hijra, Meti, third gender or anything other than a gender typically associated with a male assigned sex at birth 3. live in the Terai highway district Madesh Province 4. Maithili- or Nepali-speaking 5. Willing to be part of the study for 6 months 6. Willing to travel, if needed, to participate in group sessions For those who test HIV negative: 1. Willing to self-test 2. Have or willing to have a mobile phone 3. Not HIV tested within the last 3 months For those who test HIV positive: (a) screen positive for HIV treatment non-adherence by self-report Exclusion Criteria: 1. Cannot or will not consent to the research, 2. Female sex assigned at birth, 3. Self-identify as a man 4. Do not speak Maithli or Nepali 5. Age under 18 -

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

  • BDS

    Kathmandu, Nepal

More trials for these conditions

Other studies related to the condition(s) this trial covers.